Approximately 15–17% of men with PCa carry germline mutations, most commonly involving pathogenic variants in BRCA2 (5%), CHEK2 (2%), ATM (2%), and BRCA1 (1%) [19]. The gene discussed is BRCA2; the disease is posterior cortical atrophy.